Oncotelic Therapeutics (OTLC) Enterprise Value (2010 - 2026)
Oncotelic Therapeutics' Enterprise Value came in at $16.97 million for Q2 2026, up 3.6% from $16.38 million a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Enterprise Value (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Oncotelic Therapeutics reported Enterprise Value of $16.33 million, up 2.0% year-over-year; for FY2025, it came in at $34.27 million, up 122.4% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of 11.2% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $15.41 million in FY2024 (+1.0%), $15.26 million in FY2023 (-20.2%), $19.12 million in FY2022 (-62.6%) and $51.14 million in FY2021 (+153.8%).
- The five-year range for quarterly Enterprise Value is $7.26 million (Q3 2024) to $86.93 million (Q1 2022).
- Year-over-year, Enterprise Value increased in six of the last seven quarters, with growth averaging 83.3%.
- The fastest year-over-year change in Enterprise Value over five years came in Q3 2025 (growth of 366.6%), and the weakest in Q2 2023 (a decline of 82.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Oncotelic Therapeutics | 8.46 Mn | 7.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.97 Mn |
| Dec 31, 2025 | 34.27 Mn |
| Sep 30, 2025 | 33.86 Mn |
| Jun 30, 2025 | 16.38 Mn |
| Mar 31, 2025 | 27.64 Mn |
| Dec 31, 2024 | 15.41 Mn |
| Sep 30, 2024 | 7.26 Mn |
| Jun 30, 2024 | 11.47 Mn |
| Mar 31, 2024 | 15.19 Mn |
| Dec 31, 2023 | 15.26 Mn |
| Sep 30, 2023 | 11.22 Mn |
| Jun 30, 2023 | 11.35 Mn |
| Mar 31, 2023 | 19.31 Mn |
| Dec 31, 2022 | 19.12 Mn |
| Sep 30, 2022 | 26.94 Mn |
| Jun 30, 2022 | 65.13 Mn |
| Mar 31, 2022 | 86.93 Mn |
| Dec 31, 2021 | 51.14 Mn |
| Sep 30, 2021 | 39.39 Mn |
| Jun 30, 2021 | 51.39 Mn |
API Access
Oncotelic Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();